Australia and New Zealand survey of antimetabolite and steroid use in trabeculectomy surgery

Journal of Glaucoma

Volumn 17, Issue 6, 2008, Pages 423-430

  Liu, Lance ^a,e   Siriwardena, Dilani ^b,c,d   Khaw, Peng Tee ^b,c,d  

^a ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

^b and University of Bristol   (United Kingdom)

^c MOORFIELDS EYE HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e Preston Eye Clinic   (Australia)

Author keywords

5 fluorouracil; Mitomycin C; Survey; Topical steroids; Trabeculectomy

Indexed keywords

ANTIMETABOLITE; FLUOROURACIL; MITOMYCIN C; STEROID; GLUCOCORTICOID; MITOMYCIN;

ARTICLE; AUSTRALIA; CONJUNCTIVA; CONSULTATION; DRUG USE; DRUG UTILIZATION; GLAUCOMA; HUMAN; INTRAOPERATIVE PERIOD; MEDICAL DECISION MAKING; MEDICAL EDUCATION; NEW ZEALAND; OPHTHALMOLOGY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; QUESTIONNAIRE; RISK FACTOR; SCAR FORMATION; TRABECULECTOMY; UNITED KINGDOM; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; STATISTICS;

ANTIMETABOLITES; AUSTRALIA; CROSS-SECTIONAL STUDIES; FLUOROURACIL; GLAUCOMA; GLUCOCORTICOIDS; HEALTH CARE SURVEYS; HUMANS; MITOMYCIN; NEW ZEALAND; OPHTHALMOLOGY; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; TRABECULECTOMY;

EID: 58149133955     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/IJG.0b013e31816224d8     Document Type: Article

References (41)

1. Gaskin BJ, Carroll SC, Gamble G, et al. Glaucoma management trends in Australia and New Zealand. Clin Experiment Ophthalmol. 2006;34:208-212.
2. Hitchings RA, Grierson I. Clinico pathological correlation in eyes with failed fistulizing surgery. Trans Ophthalmol Soc UK. 1983;103(Pt 1):84-88.
3. Budenz DL, Hoffman K, Zacchei A. Glaucoma filtering bleb dysesthesia. Am J Ophthalmol. 2001;131:626-630.
4. Stamper RL, McMenemy MG, Lieberman MF. Hypotonous maculopathy after trabeculectomy with subconjunctival 5-fluorou-racil. Am J Ophthalmol. 1992;114:544-553.
5. Mochizuki K, Jikihara S, Ando Y, et al. Incidence of delayed onset infection after trabeculectomy with adjunctive mitomycin C or 5-fluorouracil treatment. Br J Ophthalmol. 1997;81:877-883.
6. Soltau JB, Rothman RF, Budenz DL, et al. Risk factors for glaucoma filtering bleb infections. Arch Ophthalmol. 2000;118: 338-342.
7. Jampel HD, Quigley HA, Kerrigan-Baumrind LA, et al. Risk factors for late-onset infection following glaucoma filtration surgery. Arch Ophthalmol. 2001;119:1001-1008.
8. Siriwardena D, Edmunds B, Wormald RP, et al. National survey of antimetabolite use in glaucoma surgery in the United Kingdom. Br J Ophthalmol. 2004;88:873-876.
9. Joshi AB, Parrish RK II, Feuer WF. 2002 survey of the American Glaucoma Society: practice preferences for glaucoma surgery and antifibrotic use. J Glaucoma. 2005;14:172-174.
10. Liu L. Australian and New Zealand survey of glaucoma practice patterns. Clin Experiment Ophthalmol. 2007. doi: 10.1111/j.1442-9071. 2007.01623.x.
11. Yorston D, Khaw PT. A randomised trial of the effect of intraoperative 5-FU on the outcome of trabeculectomy in east Africa. Br J Ophthalmol. 2001;85:1028-1030.
12. Uchida S, Suzuki Y, Araie M, et al. Long-term follow-up of initial 5-fluorouracil trabeculectomy in primary open-angle glaucoma in Japanese patients. J Glaucoma. 2001;10:458-465.
13. Broadway DC, Grierson I, O'Brien C, et al. Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol. 1994;112:1446-1454.
14. The Fluorouracil Filtering Surgery Study Group. Five-year follow-up of the Fluorouracil Filtering Surgery Study. Am J Ophthalmol. 1996;121:349-366.
15. Towler HM, McCluskey P, Shaer B, et al. Long-term follow-up of trabeculectomy with intraoperative 5-fluorouracil for uveitis-related glaucoma. Ophthalmology. 2000;107:1822-1828.
16. Tsai JC, Feuer WJ, Parrish RK II, et al. 5-Fluorouracil filtering surgery and neovascular glaucoma. Long-term follow-up of the original pilot study. Ophthalmology. 1995;102:887-892; discussion 892-893.
17. Mandal AK, Bagga H, Nutheti R, et al. Trabeculectomy with or without mitomycin-C for paediatric glaucoma in aphakia and pseudophakia following congenital cataract surgery. Eye. 2003;17: 53-62.
18. Molteno AC, Straughan JL, Ancker E. Control of bleb fibrosis after glaucoma surgery by anti-inflammatory agents. S Afr Med J. 1976;50:881-885.
19. The Fluorouracil Filtering Surgery Study Group. Fluorouracil Filtering Surgery Study one-year follow-up. Am J Ophthalmol. 1989;108:625-635.
20. Khaw PT. Advances in glaucoma surgery: evolution of antimetabolite adjunctive therapy. J Glaucoma. 2001;10:S81-S84.
21. Wells AP, Cordeiro MF, Bunce C, et al. Cystic bleb formation and related complications in limbus-versus fornix-based conjunctival flaps in pediatric and young adult trabeculectomy with mitomycin C. Ophthalmology. 2003;110:2192-2197.
22. Wormald R, Wilkins MR, Bunce C. Post-operative 5-fluorouracil for glaucoma surgery. Cochrane Database Syst Rev. 2000; CD001132.
23. Wells AP, Bunce C, Khaw PT. Flap and suture manipulation after trabeculectomy with adjustable sutures: titration of flow and intraocular pressure in guarded filtration surgery. J Glaucoma. 2004; 13:400-406.
24. Walland MJ. Glaucoma treatment in Australia: changing patterns of therapy 1994-2003. Clin Experiment Ophthalmol. 2004;32: 590-596.
25. Macleod SM, Clark R, Forrest J, et al. A review of glaucoma treatment in Scotland 1994-2004. Eye. 2007. In press.
26. Strutton DR, Walt JG. Trends in glaucoma surgery before and after the introduction of new topical glaucoma pharmacotherapies. J Glaucoma. 2004;13:221-226.
27. Roth SM, Spaeth GL, Starita RJ, et al. The effects of postoperative corticosteroids on trabeculectomy and the clinical course of glaucoma: five-year follow-up study. Ophthalmic Surg. 1991;22: 724-729.
28. Liebmann J, Kim J. Trabeculectomy. In: Weinreb R, Crowston J, eds. Glaucoma Surgery-Open Angle Glaucoma Consensus Series-2. The Netherlands: Kugler Publications; 2005:57-64.
29. Yanoff M, Fine BS. Basic principles of pathology. In: Yanoff M, Fine BS, eds. Ocular Pathology. 4th ed. Barcelona: Mosby-Wolfe; 1996:1-26.
30. Marquardt D, Lieb WE, Grehn F. Intensified postoperative care versus conventional follow-up: a retrospective long-term analysis of 177 trabeculectomies. Graefes Arch Clin Exp Ophthalmol. 2004; 242:106-113.
31. Schwartz AL, Anderson DR. Trabecular surgery. Arch Ophthalmol. 1974;92:134-138.
32. Broadway DC, Grierson I, Hitchings RA. Local effects of previous conjunctival incisional surgery and the subsequent outcome of filtration surgery. Am J Ophthalmol. 1998;125:805-818.
33. Khaw PT, Chang L, Wong TT, et al. Modulation of wound healing after glaucoma surgery. Curr Opin Ophthalmol. 2001;12:143-148.
34. Wilkins M, Indar A, Wormald R. Intra-operative mitomycin C for glaucoma surgery. Cochrane Database Syst Rev. 2005;CD002897.
35. Wilkins MR, Occleston NL, Kotecha A, et al. Sponge delivery variables and tissue levels of 5-fluorouracil. Br J Ophthalmol. 2000;84:92-97.
36. Sturmer J, Broadway DC, Hitchings RA. Young patient trabeculectomy. Assessment of risk factors for failure. Ophthalmology. 1993;100:928-939.
37. Egbert PR, Williams AS, Singh K, et al. A prospective trial of intraoperative fluorouracil during trabeculectomy in a black population. Am J Ophthalmol. 1993;116:612-616.
38. Shingleton BJ, Crandall A, Johnstone M, et al. Medical treatment patterns of ASCRS members for primary open-angle glaucoma -1998 survey. J Cataract Refract Surg. 1999;25:118-127.
39. Johnstone MA, Shingleton BJ, Crandall AS, et al. Glaucoma surgery treatment patterns of ASCRS members -2000 survey. J Cataract Refract Surg. 2001;27:1864-1871.
40. Chen PP, Yamamoto T, Sawada A, et al. Use of antifibrosis agents and glaucoma drainage devices in the American and Japanese Glaucoma Societies. J Glaucoma. 1997;6:192-196.
41. Gore-Felton C, Koopman C, Bridges E, et al. An example of maximizing survey return rates. Methodological issues for health professionals. Eval Health Prof. 2002;25:152-168.